FNY Investment Advisers’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Sell
150
-50
-25% -$1.39K ﹤0.01% 700
2026
Q1
$3K Sell
200
-70
-26% -$1.34K ﹤0.01% 644
2025
Q4
$6K Buy
270
+220
+440% +$5.67K ﹤0.01% 715
2025
Q3
$1K Sell
50
-120
-71% -$2.86K ﹤0.01% 1187
2025
Q2
$2K Hold
170
﹤0.01% 864
2025
Q1
$2K Buy
170
+60
+55% +$1.2K ﹤0.01% 651
2024
Q4
$2K Buy
+110
New +$3.14K ﹤0.01% 597
2018
Q3
Sell
-99
Closed -$3K 1277
2018
Q2
$3K Buy
+99
New +$2.32K ﹤0.01% 736

Other funds holding STAA

FNY Investment Advisers's STAA Position: Q2 2026 in Review

FNY Investment Advisers reduced its STAAR Surgical (STAA) stake by 25% in Q2 2026, selling an estimated $1.39K and leaving 150 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

FNY Investment Advisers first reported a position in STAA in Q2 2018 and has held it in 8 quarters since. The position peaked at $6K in Q4 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • FNY Investment Advisers held 150 shares of STAAR Surgical worth $4K as of Q2 2026.
  • FNY Investment Advisers sold 50 STAAR Surgical shares in Q2 2026, an estimated $1.39K.
  • STAAR Surgical made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #700 holding.
  • FNY Investment Advisers first reported a position in STAAR Surgical in Q2 2018 and has held it in 8 quarters since.
  • FNY Investment Advisers's STAAR Surgical position peaked at $6K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.